跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OLMESARTAN/ AMLODIPINE HCT - MYL 40/5/12.5 olmesartan medoxomil 40mg, amlodipine (as besilate) 5mg and hydrochlorothiazide 12.5 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
OLMESARTAN/ AMLODIPINE HCT - MYL 40/5/12.5 olmesartan medoxomil 40mg, amlodipine (as besilate) 5mg and hydrochlorothiazide 12.5 mg tablet blister pack
Approved
STANDARD
OLMESARTAN/ AMLODIPINE HCT - MYL 40/5/12.5 olmesartan medoxomil 40mg, amlodipine (as besilate) 5mg and hydrochlorothiazide 12.5 mg tablet blister pack
ORGANON PHARMA PTY LTD
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
35fec68ee68dde81
Company
ORGANON PHARMA PTY LTD
Type
Standard
Approval Details
Approval Id
35fec68ee68dde81
Product Name
OLMESARTAN/ AMLODIPINE HCT - MYL 40/5/12.5 olmesartan medoxomil 40mg, amlodipine (as besilate) 5mg and hydrochlorothiazide 12.5 mg tablet blister pack
Artg Id
273593
Artg Name
OLMESARTAN/ AMLODIPINE HCT - MYL 40/5/12.5 olmesartan medoxomil 40mg, amlodipine (as besilate) 5mg and hydrochlorothiazide 12.5mg tablet blister pack
Sponsor
ORGANON PHARMA PTY LTD
Company Detail Path
/organization/organon-pharma-pty-ltd
Artg Date
2016-06-07
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
35fec68ee68dde81
Type
Standard
Back to TGA Approvals